BACKGROUND: BCR-ABL tyrosine kinase inhibitors (TKIs) have been increasingly linked to pulmonary arterial hypertension (PAH) since 2009, although supporting evidence is limited. Our objective was to ...
The feature, called "Dear Algo," lets Threads users personalize what content they see by publicly posting an AI prompt.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results